BRINERDIN Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

brinerdin

dihydroergocristine 0.5mg clopamide 5mg, reserpine 0.1mg

BRINERDIN TABLETS (POM) Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

brinerdin tablets (pom)

dihydroergocristine 0.5g, clopamide 5mg, reserpine 0.1mg

BRINERDIN X 30'S,100'S Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

brinerdin x 30's,100's

dihydroergocristin 0.5mg, clopamide 5mg, reserpine 0.1mg

NORMOPRESS TABLETS (POM) Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

normopress tablets (pom)

reserpine 0.1mg,dihydroergotoxime mesylate 0.1mg,clopamide 5mg

VISKALDIX TABS. Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

viskaldix tabs.

pindolol 10mg clopamide 5mg

BRINERDIN TABS Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

brinerdin tabs

reserpine 0.1mg. clopamide 5mg dihydroergocristine 0.5mg

MYLAN-PINDOLOL TABLET Canada - English - Health Canada

mylan-pindolol tablet

mylan pharmaceuticals ulc - pindolol - tablet - 5mg - pindolol 5mg - beta-adrenergic blocking agents

MYLAN-PINDOLOL TABLET Canada - English - Health Canada

mylan-pindolol tablet

mylan pharmaceuticals ulc - pindolol - tablet - 10mg - pindolol 10mg - beta-adrenergic blocking agents

CERTICAN everolimus 1mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

certican everolimus 1mg tablet blister pack

novartis pharmaceuticals australia pty ltd - everolimus, quantity: 1 mg - tablet, uncoated - excipient ingredients: butylated hydroxytoluene; lactose monohydrate; hypromellose; magnesium stearate; crospovidone; lactose - certican is indicated for the prophylaxis of organ rejection in adult patients at mild to moderate immunological risk receiving an allogeneic renal or cardiac transplant and in adult patients receiving an allogeneic hepatic transplant (see precautions).

CERTICAN everolimus 0.75mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

certican everolimus 0.75mg tablet blister pack

novartis pharmaceuticals australia pty ltd - everolimus, quantity: 0.75 mg - tablet, uncoated - excipient ingredients: butylated hydroxytoluene; lactose monohydrate; hypromellose; magnesium stearate; crospovidone; lactose - certican is indicated for the prophylaxis of organ rejection in adult patients at mild to moderate immunological risk receiving an allogeneic renal or cardiac transplant and in adult patients receiving an allogeneic hepatic transplant (see precautions).